24 research outputs found

    The MADP Toolbox: An Open-Source Library for Planning and Learning in (Multi-)Agent Systems

    Get PDF
    This article describes the MultiAgent Decision Process (MADP) toolbox, a software library to support planning and learning for intelligent agents and multiagent systems in un- certain environments. Some of its key features are that it sup- ports partially observable environments and stochastic tran- sition models; has unified support for single- and multiagent systems; provides a large number of models for decision- theoretic decision making, including one-shot decision mak- ing (e.g., Bayesian games) and sequential decision mak- ing under various assumptions of observability and coopera- tion, such as Dec-POMDPs and POSGs; provides tools and parsers to quickly prototype new problems; provides an ex- tensive range of planning and learning algorithms for single- and multiagent systems; and is written in C++ and designed to be extensible via the object-oriented paradigm

    Crystallographic Evidence of Drastic Conformational Changes in the Active Site of a Flavin-Dependent

    Get PDF
    The soil actinomycete Kutzneria sp. 744 produces a class of highly decorated hexadepsipeptides, which represent a new chemical scaffold that has both antimicrobial and antifungal properties. These natural products, known as kutznerides, are created via nonribosomal peptide synthesis using various derivatized amino acids. The piperazic acid moiety contained in the kutzneride scaffold, which is vital for its antibiotic activity, has been shown to derive from the hydroxylated product of l-ornithine, l-N5-hydroxyornithine. The production of this hydroxylated species is catalyzed by the action of an FAD- and NAD(P)H-dependent N-hydroxylase known as KtzI. We have been able to structurally characterize KtzI in several states along its catalytic trajectory, and by pairing these snapshots with the biochemical and structural data already available for this enzyme class, we propose a structurally based reaction mechanism that includes novel conformational changes of both the protein backbone and the flavin cofactor. Further, we were able to recapitulate these conformational changes in the protein crystal, displaying their chemical competence. Our series of structures, with corroborating biochemical and spectroscopic data collected by us and others, affords mechanistic insight into this relatively new class of flavin-dependent hydroxylases and adds another layer to the complexity of flavoenzymes.National Center for Research Resources (U.S.) (P41RR012408)National Institute of General Medical Sciences (U.S.) (P41GM103473

    Potential therapeutic applications of microbial surface-activecompounds

    Get PDF
    Numerous investigations of microbial surface-active compounds or biosurfactants over the past two decades have led to the discovery of many interesting physicochemical and biological properties including antimicrobial, anti-biofilm and therapeutic among many other pharmaceutical and medical applications. Microbial control and inhibition strategies involving the use of antibiotics are becoming continually challenged due to the emergence of resistant strains mostly embedded within biofilm formations that are difficult to eradicate. Different aspects of antimicrobial and anti-biofilm control are becoming issues of increasing importance in clinical, hygiene, therapeutic and other applications. Biosurfactants research has resulted in increasing interest into their ability to inhibit microbial activity and disperse microbial biofilms in addition to being mostly nontoxic and stable at extremes conditions. Some biosurfactants are now in use in clinical, food and environmental fields, whilst others remain under investigation and development. The dispersal properties of biosurfactants have been shown to rival that of conventional inhibitory agents against bacterial, fungal and yeast biofilms as well as viral membrane structures. This presents them as potential candidates for future uses in new generations of antimicrobial agents or as adjuvants to other antibiotics and use as preservatives for microbial suppression and eradication strategies

    Effective Approximations for Planning with Spatially Distributed Tasks

    No full text
    Planning in cooperative multiagent systems can be neatly formalized using Multi-Agent MDPs, but solving these models is computationally costly. This paper introduces a sub-class of problems called spatial task allocation problems (SPATAPS) that model problems in which a team of agents has to service a dynamically changing set of tasks that is spatially distributed in the environment. We propose to tackle SPATAPS using online, distributed planning by combining subjective agent approximations with restriction of attention to current tasks in the world. An empirical evaluation shows that the combination of both strategies allows to scale to very large problems, while providing near-optimal solutions

    Bactericidal synergy of lysostaphin in combination with antimicrobial peptides

    No full text
    Drug-resistant staphylococci constitute a serious problem that urgently requires the discovery of new therapeutic agents. There has been a resurgence in interest in using lysostaphin (a specific anti-staphylococcal enzyme) as a treatment for infections caused by these important pathogens. However, bacterial resistance to lysostaphin is a problem, but the use of a combination treatment may surmount this issue. In this present study, using viable counts from suspension incubations, lysostaphin is shown to be synergistically bactericidal in combination with various conventional antimicrobial peptides, the antimicrobial protein bovine lactoferrin, a lantibiotic (nisin), and certain lipopeptides used clinically (colistin, daptomycin and polymyxin B). Combinations that act in synergy are of clinical importance as these reduce the doses of the compounds needed for effective treatments and decrease the chances of resistance being selected. The use of lysostaphin in combination with a peptide may represent a new avenue in tackling drug-resistant staphylococci
    corecore